Agilent Technologies, Inc. (A) Fair Value 2026

A · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

9.1 /10

32 fundamental signals · 10 models active

Value Trap Risk

SAFE (6/100)

Quick Summary — As of 2026-08-27, Agilent Technologies, Inc. (A) trades at $157.69, versus a $62.69 median fair value across its 10 active models — 60.2% below the current price. QOC: 9.1/10. Value Trap Risk: 6/100 (SAFE). 10/13 models active. Within that set, the Bayesian DCF component alone returns $61.15.

Key Facts

Ticker
A
Price
$157.69
Quality Score
9.1/10
Value Trap Risk
6/100
Models Active
10/13
Last Updated
Strength: Quality Score of 9.1/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Is Agilent Technologies, Inc. (A) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Agilent Technologies, Inc. (A) appears overvalued as of : the median of 10 independent fair value estimates is $62.69, 60.2% below the current price of $157.69. Estimates range from $28.93 to $197.41. A scores 9.1/10 on fundamental quality and 6/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. A’s -60.2% gap is wider than that market norm, and the Diagnostics & Research sector median is -54.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Agilent Technologies, Inc. Stock in 2026? →

What Fair Value Does Each Model Give A?

10 Intrinsic Value Models vs. Current Price ($157.69)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $61.15 -61.2%
Intrinsic · High Conviction
 $41.22 -73.9%
Ensemble · Low Conviction
 $64.23 -59.3%
Intrinsic · High Conviction
 $39.75 -74.8%
Unlock the Full Matrix

Access 6 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is A's Fair Value Range?

Spread across 10 independent models · $28.93 to $197.41

CirclFi's 10 active models place Agilent Technologies, Inc. (A) between $28.93 and $197.41 per share, a spread of 269% of the median. The median of that range — $62.69 — is the fair value CirclFi publishes for A, against a current price of $157.69.

Low · Markov DDMHigh · Regime Cross
$28.93median $62.69$197.41
Where the range comes from
Most bearish modelMarkov DDM$28.93
Most bullish modelRegime Cross-Sectional$197.41
Model agreement1 bullish · 9 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for A. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on A, not a CirclFi price target. How each model works →

What Is Agilent Technologies, Inc. (A) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Agilent Technologies, Inc.'s intrinsic value is estimated at $62.69, suggesting the stock is overvalued at its current price of $157.69. With 9 out of 10 models flagging downside (-60.2% vs price), the market may be pricing in unsustainable growth. Model dispersion is worth noting: Regime Cross targets $197.41 (+25.2%), versus Markov DDM at $28.93 (-81.7%). This +106.8% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About A?

10 of 13 models are currently active for A. Of these, 1 model suggests upside while 9 models suggest overvaluation. Taken together, their median fair value for A is $62.69 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $61.15 on its own, implying -61.2% downside from the current price. See which stocks rank higher →

How Does A Rank in Diagnostics & Research?

Among 52 Diagnostics & Research stocks, A ranks #3 by Quality of Company score. CirclFi's QOC score of 9.1/10 evaluates 32 fundamental signals. A score of 9.1 places A in the top tier.

As a biopharma enterprise, Agilent Technologies, Inc. operates in a sector where revenue per drug is a critical driver of valuation. Investors evaluating A should weigh these sector-specific dynamics alongside our model-derived fair values.

Is A a Value Trap?

CirclFi's Value Trap algorithm assigns A a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Agilent Technologies, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Agilent Technologies, Inc. is rated at 9.1/10. This elite-tier score ranks among the highest-quality businesses in our coverage universe.

The gap between the most bullish and bearish model spans +106.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every A valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across A's 10 active models, average confidence is 55%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Agilent Technologies, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

9 related Diagnostics & Research stocks with 13-model coverage

MEDPMedpace Holdings, Inc.QOC 9.3VCYTVeracyte, Inc.QOC 8.8IDXXIDEXX Laboratories, Inc.QOC 9.5ILMNIllumina, Inc.QOC 8.8MDXHMDxHealth SAQOC 2.3MTDMettler-Toledo International Inc.QOC 8.7LDDDLongduoduo Company LimitedQOC 7.5NEONeoGenomics, Inc.QOC 6.6BIAFbioAffinity Technologies, Inc.QOC 5.0

Read investment analysis: MEDP · VCYT · IDXX · ILMN · MDXH · MTD · LDDD · NEO · BIAF

Which Other Stocks Have a Similar Quality Score to A?

7 companies across all industries closest to A’s Quality of Company score of 9.1/10.

TPLTexas Pacific Land CorporationQOC 9.1CCEPCoca-Cola Europacific Partners PLCQOC 9.1TXRHTexas Roadhouse, Inc.QOC 9.1MSIMotorola Solutions, Inc.QOC 9.1ANFAbercrombie & Fitch Co.QOC 9.1AITApplied Industrial Technologies, Inc.QOC 9.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: TPL · CCEP · TXRH · MSI · ANF · AIT · NVDA

What Else Do Investors Ask About Agilent Technologies, Inc.’s Valuation?

What is Agilent Technologies, Inc.'s intrinsic value in 2026?

CirclFi puts Agilent Technologies, Inc. (A)'s intrinsic value at $62.69 — the median of 10 independent model estimates as of 2026-08-27, ranging from $28.93 to $197.41. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $61.15 on its own. The Quality of Company score is 9.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is A overvalued or undervalued right now?

At $157.69, 1 of 10 active models suggest A may be undervalued, while 9 indicate potential overvaluation. The median of all 10 fair value estimates is $62.69, 60.2% below the current price of $157.69 — a consensus view that A is overvalued. The assessment depends on which methodology best fits Agilent Technologies, Inc.'s business model in Diagnostics & Research.

What does a Quality of Company score of 9.1 mean for A?

Agilent Technologies, Inc.'s QOC of 9.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on A?

CirclFi analyzes A with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on A?

Of the 10 models currently active on A, Regime Cross-Sectional is the most bullish at $197.41 per share, and Markov DDM is the most bearish at $28.93. CirclFi's published fair value for A is the median of that range, $62.69, not either extreme. The gap between the two ends equals 269% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is A a value trap in 2026?

Agilent Technologies, Inc.'s Value Trap score is 6/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Agilent Technologies, Inc. (A) has a median fair value of $62.69 — 60.2% below the current price of $157.69 — as of 2026-08-27.” Source: circlfi.com/stock/A/ · Methodology
Primary sources for this A valuation
  • Financial statements: Agilent Technologies, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001090872) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for A as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on A.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for A Unlock All 10 — $39/mo